BRANCHBURG, N.J., May 21, 2025 /PRNewswire/ -- The European Food Safety Authority (EFSA) Panel on Nutrition, Novel Foods and Food…
Allschwil, Switzerland, May 20, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs…
ASHBURN, Va., May 6, 2025 /PRNewswire/ -- DXC Technology, a leading Fortune 500 global technology services provider, today announced that…
PRESS RELEASEMÉRIGNAC, FRANCE – 30 APRIL 2025 EXOSENS ANNOUNCES THE AVAILABILITY OF DOCUMENTS AND INFORMATION RELATING TO THE COMBINED GENERAL MEETING…
PRESS RELEASEMÉRIGNAC, FRANCE – 30 APRIL 2025 EXOSENS ANNOUNCES THE AVAILABILITY OF ITS 2024 UNIVERSAL REGISTRATION DOCUMENT Exosens announces today that…
MUMBAI, India, March 13, 2025 /PRNewswire/ -- MSI, the innovative computing manufacturer in gaming, creator, and business laptops has announced…
Clarifai's AI Orchestration Platform Will Now Be Accessible in AWS Marketplace WASHINGTON, March 13, 2025 /PRNewswire/ -- Clarifai, a global…
The smartest AI global HR advisor, G-P Gia, thinks like a lawyer and cuts the cost and time of compliance…
Availability of the revised financial statements for Sanofi excluding Opella Paris, France – December 6, 2024. Following the press release…
November 21, 2024 16:51 ET | Source: Zevra Therapeutics MIPLYFFA, the first FDA-approved treatment for Niemann-Pick disease type C, is…
